Treatment of Glycogen Storage Disease Type III in Infants and Young Children
This protocol addresses the dietary management of infants and young children diagnosed with glycogen storage disease type III — subtype IIIa or IIIb. The primary clinical objective in this age group is the prevention of hypoglycemia.
Clinical Scenario
The patient is an infant or young child with confirmed GSD type III (subtype IIIa or IIIb). The central challenge at this stage is maintaining safe blood glucose levels, as hypoglycemia is the key initial risk driving all dietary decisions in this population.
Treatment Approach (Partial Overview)
Management centres on structured dietary modification — specifically controlled feeding patterns to prevent fasting and carbohydrate-based supplementation introduced at an appropriate developmental stage — with additional protein-focused guidance for children presenting with myopathy or growth failure covered in the complete protocol.
Target: Blood glucose 70–140 mg/dL
References
DOI: 10.1097/GIM.0b013e3181e655b6
- The initial focus of the diet for the infant and young child with either GSD IIIa or IIIb is to prevent hypoglycemia.
- Small, frequent feedings and the avoidance of fasting are generally agreed on as the first step.
- The child with myopathy and growth failure should be started on a high protein diet.
- Therefore, without randomly checking BG levels, they would not know if their diet and/or CS schedule were maintaining their BG levels in the normal range of 70–140 mg/dL.
View source ↗